OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-11 Cr | ₹-8.73 Cr | ₹1.66 Cr | ₹1.46 Cr | ₹1.34 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-11 Cr |
| Mar2024 | ₹-8.73 Cr |
| Mar2023 | ₹1.66 Cr |
| Mar2022 | ₹1.46 Cr |
| Mar2021 | ₹1.34 Cr |
How is Deferred Tax Assets / Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-11 Cr | Negative | |
| Mar2024 | ₹-8.73 Cr | Negative | |
| Mar2023 | ₹1.66 Cr | 13.55 | |
| Mar2022 | ₹1.46 Cr | 9.03 | |
| Mar2021 | ₹1.34 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹218.4 Cr | 7.1% | 9.1% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | 1.7% | -5.7% | -7.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | 0.8% | -6.7% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | 0.6% | 4.3% | 24.4% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -4.7% | -12.3% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 6.3% | -2.1% | -4.1% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 7.1% |
9.1% |
-24.7% |
| SENSEX | -1.7% |
-4.3% |
6.2% |
You may also like the below Video Courses